Fragments of the human ZN-alpha2-glycolprotein and their use in methods of treatment of obesity

Details for Australian Patent Application No. 2002339678 (hide)

Owner Serono Genetics Institute S.A.

Inventors Chumakov, Ilya; Guerassimenko, Oxana

Agent FB Rice

Pub. Number AU-B-2002339678

PCT Number PCT/IB02/04598

PCT Pub. Number WO2003/050281

Priority 60/327,725 05.10.01 US

Filing date 3 October 2002

Wipo publication date 23 June 2003

Acceptance publication date 25 October 2007

International Classifications

C12N 15/09 (2006.01) Mutation or genetic engineering - Recombinant DNA-technology

A61K 38/00 (2006.01) Medicinal preparations containing peptides

A61P 3/04 (2006.01) Drugs for disorders of the metabolism

A61P 3/06 (2006.01) Drugs for disorders of the metabolism

A61P 3/10 (2006.01) Drugs for disorders of the metabolism

A61P 9/10 (2006.01) Drugs for disorders of the cardiovascular system

A61P 9/12 (2006.01) Drugs for disorders of the cardiovascular system

C07K 14/47 (2006.01) Peptides having more than 20 amino acids

C12N 1/15 (2006.01) Micro-organisms, e.g. protozoa - modified by introduction of foreign genetic material

C12N 1/19 (2006.01) Micro-organisms, e.g. protozoa - modified by introduction of foreign genetic material

C12N 1/21 (2006.01) Micro-organisms, e.g. protozoa - modified by introduction of foreign genetic material

C12N 5/10 (2006.01) Undifferentiated human, animal or plant cells, e.g. cell lines - Cells modified by introduction of foreign genetic material, e.g. virus-transformed cells

C12N 15/12 (2006.01) Mutation or genetic engineering - Genes encoding animal proteins

A61K 9/00 (2006.01) Medicinal preparations characterised by special physical form

A61K 9/48 (2006.01) Medicinal preparations characterised by special physical form - Preparations in capsules, e.g. of gelatin, of chocolate

A61K 48/00 (2006.01) Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases

Event Publications

27 February 2003 Complete Application Filed

  Priority application(s): 60/327,725 05.10.01 US

28 August 2003 Application Open to Public Inspection

  Published as AU-B-2002339678

25 November 2004 Change of Name(s) of Applicant(s), Section 104

  Genset S.A. The name of the applicant has been changed to Serono Genetics Institute S.A.

25 October 2007 Application Accepted

  Published as AU-B-2002339678

22 November 2007 Corrigenda

  Applications Accepted - Name Index Under the name Serono Genetics Institute S.A., Application No. 2002339678, under INID (54) correct the invention title to read Fragments of the human ZN-alpha2-glycoprotein and their use in methods of treatment of obesity

3 April 2008 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2002339679-GLUCOMIN AGONISTS AND ANTAGONISTS FOR USE IN THE TREATMENT OF METABOLIC DISORDERS

2002339677-A METHOD AND SYSTEM FOR ESTIMATING OBJECTIVE QUALITY OF COMPRESSED VIDEO DATA